Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corporation

NNYSE:AP
6.23
USD
-1.12
(-15.24%)
-2.58EPS
182.43MMarket Cap
Mar 17Next Earn
Ampco-Pittsburgh Corporation
NYSE:AP
(New York Stock Exchange)

Recent

price

6.23

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
31.88
33.42
28.33
27.13
26.22
22.85
27.77
31.24
33.69
31.6
23.02
18.2
20.2
21.53
21.03
21.56
21.18
Revenue per Share
1.51
2.07
0.81
1.2
-0.11
0.13
-6.68
-0.98
-5.57
-1.67
0.56
-0.2
0.18
-2.04
0.02
-3.28
-2.78
Basic EPS, GAAP
0.78
0.63
1.53
2.51
0.64
1.06
-1.36
-2.34
-1.32
-1.43
1.76
-1.64
-2.27
-1.23
0.29
-0.4
0.58
Free Cash Flow per Basic Share
0.72
0.72
0.72
0.72
0.72
0.72
0.44
0.18
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
19.1
18.68
18.57
22.65
19.68
20.25
12.05
12.86
7.01
3.87
4.18
5.36
5.38
3.09
2.95
1.61
1.55
Book Value per Share
19.1
18.68
18.57
22.65
19.68
20.14
11.11
11.97
6.27
3.26
3.79
5.04
5.11
2.84
2.73
1.38
1.35
Tangible Book Value per Share
10
10
10
10
10
10
12
12
12
13
14
19
19
20
20
20
20
Basic Weighted Avg Shares
327
345
293
281
273
238
332
385
419
398
329
345
390
422
418
434
432
Sales/Revenue/Turnover
13.65
10.66
5.4
4.51
1.86
-3.74
-7.01
-3.47
-2.83
-0.22
2.1
0.65
0.32
1.42
1.91
1.39
2.57
Operating Margin (%)
9
10
11
11
12
12
20
21
21
19
19
18
17
18
19
22
17
Depreciation Expense
15
21
8
12
-1
1
-80
-12
-69
-21
8
-4
3
-40
- -
-66
-57
Net Income, GAAP
35.28
37.19
34.4
21.39
- -
58.25
- -
- -
- -
- -
- -
- -
28.37
- -
53.41
- -
- -
Effective Tax Rate (%)
4.73
6.18
2.85
4.43
-0.44
0.58
-24.05
-3.14
-16.53
-5.27
2.43
-1.12
0.88
-9.45
0.1
-15.22
-13.11
Profit Margin (%)
128
139
151
160
145
138
77
96
60
69
67
84
115
120
112
109
93
Working Capital
- -
- -
- -
- -
- -
- -
25
47
32
54
28
44
96
120
120
122
109
LT Debt
197
193
192
235
205
211
150
162
93
56
85
112
113
72
71
48
50
Total Equity
7.95
11.01
5.2
10.04
- -
0.95
- -
- -
- -
- -
- -
- -
1
- -
2.78
- -
- -
Return on Invested Capital (%)
7.78
10.33
4.14
5.57
- -
0.66
- -
- -
- -
- -
- -
- -
3.38
- -
1.92
- -
- -
Return on Capital (%)
8.22
10.94
4.34
5.82
-0.54
0.66
-44.43
-7.88
-56.25
-30.75
12.7
-4.3
3.3
-48.32
0.73
-144.37
-122.9
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
20
18
15
LT Borrowings
115
120
106
LT Finance Leases
4
4
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
21
21
Market Capitalization
136
178
182

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
249
248
231
Cash, Cash Equivalents & STI
9
7
9
Accounts Receivable, Net
96
88
75
Inventories
105
114
109
Total Current Liabilities
142
140
138
Payables & Accruals
65
60
57
ST Debt
20
18
15
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-8.81%
-7.41%
-32.53%
Free Cash Flow
-103.02%
-117.96%
-238.17%
Net Income, GAAP
-2,262.32%
-3,378.13%
-15,183.79%
Sales/Revenue/Turnover
7.07%
5.83%
3.79%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
110
111
96
101
418
2025
104
113
108
109
434
2026
108
103
112
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.14
0.1
-0.1
0.16
0.02
2025
0.06
-0.36
-0.11
-2.85
-3.28
2026
-0.04
0.07
0.02
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Ampco-Pittsburgh Corporation manufactures and sells highly engineered specialty metal products and customized equipment for commercial and industrial users worldwide. The company operates through two principal segments: Forged and Cast Engineered Products, which produces forged hardened steel rolls, cast rolls, and open-die forged products utilized in hot and cold rolling mills by steel, aluminum, and other metal producers, as well as ingot and engineered products for automotive tooling, plastic injection molding, oil and gas, infrastructure, and general industrial applications; and Air and Liquid Processing, which manufactures custom-engineered finned tube heat exchange coils, large custom-designed air handling systems for institutional, pharmaceutical, healthcare, and biotechnology markets including gene therapy and MRI labs, and centrifugal pumps for fossil-fueled power generation, marine defense including the U.S. Navy surface fleet, oil and gas, and industrial refrigeration industries. Incorporated in Pennsylvania in 1929 with corporate headquarters in Carnegie, Pennsylvania, the company maintains manufacturing facilities in the United States, England, Sweden, Slovenia, and other locations, generating the majority of its revenue from the Forged and Cast Engineered Products segment. Recent developments include the closure of its UK operations by subsidiary Union Electric Steel in June 2025, the closing of an amended and restated credit facility in June 2025, significant commercial contract wins such as $6.7 million with Ternium Mexico and $5.0 million with a European OEM mill builder announced in July 2024 with deliveries starting in 2025, record new orders and over 50% order intake growth in the Air and Liquid Processing segment for the quarter ended June 30, 2024 leading to a total sales order backlog of $360-365 million, subsidiaries' price increases on forged and cast products in March 2025, and strong Q3 2025 financial performance with 35% growth in adjusted EBITDA driven by improved pricing, higher volumes, and product mix.

Company News

  • Ampco-Pittsburgh Stock Up Post Q3 Earnings, Revenues and Backlog Rise

  • Ampco-Pittsburgh Corporation to Present at the Southwest IDEAS Investor Conference on November 18, 2026, in Dallas

  • Ampco-Pittsburgh Q3 Earnings Call Highlights

  • Ampco-Pittsburgh Corporation (AP) Q3 2026 Earnings Call Transcript

  • Ampco-Pittsburgh Corporation Announces Third Quarter 2026 Results

  • Arrowhead Pharmaceuticals Presents Plozasiran Data Highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis Rates

  • Why a wave of bomb threats is proving so difficult for Europe's aviation authorities to contain

  • Ampco-Pittsburgh Schedules Third Quarter 2026 Earnings Conference Call

  • SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026

  • Ampco-Pittsburgh Up Nearly 217% in a Year: What's Driving the Stock?

  • Ampco-Pittsburgh Corporation to Present at the Sidoti Small-Cap Virtual Investor Conference on September 23, 2026

  • Ampco-Pittsburgh: I'm Taking The Bait And Turning Bullish

  • Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia

  • Ampco-Pittsburgh vs. NN: Which Industrial Stock Is the Better Buy?

  • Ampco-Pittsburgh Stock Up Post Q2 Earnings, Orders Improve Sequentially

  • Ampco-Pittsburgh Corporation (AP) Q2 2026 Earnings Call Transcript

  • Ampco-Pittsburgh Q2 Earnings Call Highlights

  • Ampco-Pittsburgh Corporation Announces Second Quarter 2026 Results

  • Ampco-Pittsburgh Schedules Second Quarter 2026 Earnings Conference Call

  • Intuit and College Board Partner to Bring Free Financial Tools and Resources to High School Classrooms Through New AP® Business with Personal Finance Course